Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diagnosis of Myeloproliferative Neoplasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00006239
What this trial is testing

Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableLooking for participantsNCT00662090
What this trial is testing

Study for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leucemia (JMML) in Childhood

Who this might be right for
Myelodysplastic SyndromesJuvenile Myelomonocytic Leukemia
University Hospital Freiburg 260
Early research (Phase 1)Study completedNCT01629082
What this trial is testing

Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia

Who this might be right for
Myeldysplastic Syndrome (MDS)Chronic Myelomonocytic LeukemiaBone Marrow Diseases+2 more
National Heart, Lung, and Blood Institute (NHLBI) 4
Testing effectiveness (Phase 2)Study completedNCT02311569
What this trial is testing

Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation

Who this might be right for
Myeloproliferative NeoplasmPrimary MyelofibrosisEssential Thrombocythemia+1 more
Swiss Cancer Institute 39
Large-scale testing (Phase 3)Study completedNCT02292446
What this trial is testing

Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Were Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Was Available.

Who this might be right for
Polycythemia Vera
Novartis Pharmaceuticals 161
Not applicableStudy completedNCT06134102
What this trial is testing

Clinical and Laboratory Characteristics of Polycythemia Vera

Who this might be right for
Polycythemia Vera
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,150
Testing effectiveness (Phase 2)Study completedNCT04943757
What this trial is testing

Post-transplantation Benadamustine and Cyclophosphamide in Patients With Refractory Myeloid Malignancies

Who this might be right for
Myeloid Leukemia, AcuteChronic Myeloid LeukemiaMyelodysplastic Syndromes+1 more
St. Petersburg State Pavlov Medical University 50
Testing effectiveness (Phase 2)Study completedNCT04767802
What this trial is testing

PTG-300 in Patients With Polycythemia Vera and Elevated Hematocrit

Who this might be right for
Polycythemia Vera
Protagonist Therapeutics, Inc. 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07765602
What this trial is testing

Rusfertide in Adults With Polycythemia Vera in China

Who this might be right for
Polycythemia Vera
Takeda 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT03862157
What this trial is testing

Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeChronic Eosinophilic Leukemia, Not Otherwise Specified+13 more
M.D. Anderson Cancer Center 40
Not applicableLooking for participantsNCT06734637
What this trial is testing

Efficacy and Safety of Peginterferon in ET and PV.

Who this might be right for
Essential ThrombocythemiaPolycythemia Vera
Zhenya Hong 40
Testing effectiveness (Phase 2)Study completedNCT00003239
What this trial is testing

Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07719348
What this trial is testing

Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome Acute Myeloid Leukemia
Servier 64
Very early researchStudy completedNCT01822015
What this trial is testing

Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Monoblastic Leukemia (M5a)Adult Acute Monocytic Leukemia (M5b)+11 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 55
Early research (Phase 1)Study completedNCT00361049
What this trial is testing

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Cancer
Case Comprehensive Cancer Center 49
Testing effectiveness (Phase 2)Study completedNCT00219752
What this trial is testing

Safety and Efficacy of Imatinib in Chronic Myelogenous Patients Older Than 70 Years

Who this might be right for
Chronic Myeloid Leukemia
Poitiers University Hospital 30
Testing effectiveness (Phase 2)Study completedNCT02480608
What this trial is testing

Treatment of CML Patients With Imatinib and Hydroxyurea (CML2004)

Who this might be right for
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
University of Leipzig 113
Testing effectiveness (Phase 2)Active Not RecruitingNCT02790515
What this trial is testing

Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)Myeloid Sarcoma+4 more
St. Jude Children's Research Hospital 170
Not applicableStudy completedNCT01805843
What this trial is testing

Pulmonary Vasculopathy Under Second-line Therapy of Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Medical University of Graz 16
Next Page